Kovitz Investment Group Partners LLC trimmed its holdings in Nutrien Ltd. (NYSE:NTR - Free Report) by 90.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,366 shares of the company's stock after selling 61,450 shares during the quarter. Kovitz Investment Group Partners LLC's holdings in Nutrien were worth $285,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Banco Bilbao Vizcaya Argentaria S.A. raised its position in Nutrien by 60.7% during the fourth quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 29,893 shares of the company's stock valued at $1,322,000 after acquiring an additional 11,287 shares in the last quarter. Kamunting Street Capital Management L.P. increased its holdings in shares of Nutrien by 275.5% during the 4th quarter. Kamunting Street Capital Management L.P. now owns 105,705 shares of the company's stock valued at $4,730,000 after purchasing an additional 77,552 shares in the last quarter. J. Safra Sarasin Holding AG lifted its stake in shares of Nutrien by 29.2% in the 4th quarter. J. Safra Sarasin Holding AG now owns 41,153 shares of the company's stock valued at $1,840,000 after purchasing an additional 9,313 shares during the period. MYDA Advisors LLC purchased a new stake in Nutrien during the fourth quarter worth $1,208,000. Finally, Natixis grew its position in Nutrien by 22.2% during the fourth quarter. Natixis now owns 101,808 shares of the company's stock valued at $4,556,000 after buying an additional 18,521 shares during the period. 63.10% of the stock is owned by institutional investors and hedge funds.
Nutrien Trading Down 1.1 %
Shares of NTR stock traded down $0.63 on Monday, hitting $56.20. 1,588,759 shares of the stock traded hands, compared to its average volume of 2,118,042. Nutrien Ltd. has a twelve month low of $43.70 and a twelve month high of $60.87. The stock has a market capitalization of $27.44 billion, a PE ratio of 41.02, a PEG ratio of 1.19 and a beta of 0.79. The firm's 50-day moving average price is $51.50 and its two-hundred day moving average price is $49.69. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27.
Nutrien (NYSE:NTR - Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.37 by ($0.09). The firm had revenue of $5.08 billion for the quarter, compared to analyst estimates of $5.09 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. As a group, analysts anticipate that Nutrien Ltd. will post 3.72 EPS for the current year.
Nutrien Cuts Dividend
The firm also recently declared a quarterly dividend, which was paid on Thursday, April 10th. Stockholders of record on Monday, March 31st were paid a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 3.88%. The ex-dividend date was Monday, March 31st. Nutrien's dividend payout ratio (DPR) is presently 159.12%.
Wall Street Analysts Forecast Growth
NTR has been the subject of a number of analyst reports. Berenberg Bank upped their price objective on shares of Nutrien from $54.00 to $59.00 and gave the stock a "buy" rating in a research report on Tuesday, April 15th. BNP Paribas upgraded Nutrien to a "strong-buy" rating in a research report on Wednesday, April 9th. Barclays upped their target price on Nutrien from $56.00 to $59.00 and gave the stock an "equal weight" rating in a research note on Wednesday, March 5th. CIBC boosted their price target on shares of Nutrien from $64.00 to $66.00 and gave the stock an "outperformer" rating in a report on Tuesday, February 25th. Finally, The Goldman Sachs Group started coverage on shares of Nutrien in a report on Thursday, March 13th. They set a "sell" rating and a $53.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, five have given a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Nutrien presently has an average rating of "Moderate Buy" and a consensus target price of $59.27.
Get Our Latest Report on NTR
About Nutrien
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Recommended Stories
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
